Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A longitudinal single-cell atlas of treatment response in pediatric AML
Sander Lambo, Diane L. Trinh, Rhonda E. Ries, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2117-2135.e12
Open Access | Times Cited: 22

Showing 22 citing articles:

Epigenomic heterogeneity as a source of tumour evolution
Marthe Laisné, Mathieu Lupien, Céline Vallot
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8
Emerging clinical applications of single-cell RNA sequencing in oncology
Emily Boxer, Nisan Feigin, Roi Tschernichovsky, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 1
Fusion oncoproteins and cooperating mutations define disease phenotypes inNUP98-rearranged leukemia
Masayuki Umeda, Ryan Hiltenbrand, Nicole L. Michmerhuizen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AML
Andy G.X. Zeng, Ilaria Iacobucci, Sayyam Shah, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 12
Applications of single-cell technologies in drug discovery for tumor treatment
Bingyu Liu, Shunfeng Hu, Xin Wang
iScience (2024) Vol. 27, Iss. 8, pp. 110486-110486
Closed Access | Times Cited: 4
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia.
Fatemeh Alikarami‬, Hongbo Xie, Simone S. Riedel, et al.
Blood (2025)
Open Access
The chromatin accessibility landscape of pediatric AML
Ambre Giguelay, Leif S. Ludwig
Blood (2025) Vol. 145, Iss. 11, pp. 1109-1111
Closed Access
Redefining the high variable genes by optimized LOESS regression with positive ratio
Yue Xie, Zehua Jing, Pan Hai-lin, et al.
BMC Bioinformatics (2025) Vol. 26, Iss. 1
Open Access
MLL oncoprotein levels influence leukemia lineage identities
Derek H. Janssens, M. Durán, Dominik J. Otto, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
An arms‐race against resistance: leukemic stem cells and lineage plasticity
Alexander Waclawiczek, Aino‐Maija Leppä, Simon Renders, et al.
Molecular Oncology (2024) Vol. 18, Iss. 3, pp. 475-478
Open Access | Times Cited: 1
From hypoxia single‐cell gene signatures to HIF targeting of AML leukemic stem cells
Thomas Mercher, Juerg Schwaller
HemaSphere (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 1
Single-cell epigenetic and clonal analysis decodes disease progression in pediatric acute myeloid leukemia
Boyu Cui, Lanlan Ai, Minghui Lei, et al.
Blood (2024)
Open Access | Times Cited: 1
KMT2A oncoproteins induce epigenetic resistance to targeted therapies
Derek H. Janssens, M. Durán, Dominik J. Otto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Multi-omic analysis of longitudinal acute myeloid leukemia patient samples reveals potential prognostic markers linked to disease progression
Nisar Ahmed, Irene Cavattoni, William Villiers, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Single-cell technology for drug discovery and development
A Zhang, Jiawei Zou, Yue Xi, et al.
Frontiers in Drug Discovery (2024) Vol. 4
Open Access
Single-cell sequencing applications in acute myeloid leukemia
Nicolas Lecornec, Matthieu Duchmann, Raphaël Itzykson
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-15
Closed Access
ARMH1 is a novel marker associated with poor pediatric AML outcomes that affect the fatty acid synthesis and cell cycle pathways
Mojtaba Bakhtiari, Sean C. Jordan, Hope Mumme, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias
Travis J. Fleming, Mateusz Antoszewski, Sander Lambo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia
Farnaz Barneh, Joost B. Koedijk, Noa E. Wijnen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Multi-omics analysis of longitudinal patient samples reveals the molecular mechanism of AML progression
Nisar Ahmed, Irene Cavattoni, William Villiers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A scalable computational framework for annotation-independent combinatorial target identification in scRNA-seq databases
Maximilian Buser, Carsten Marr
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Single-cell analysis of pediatric acute myeloid leukemia samples uncovers treatment-resistant stem and mast cells
Denis Ohlstrom, Mojtaba Bakhtia, Hope Mumme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Single-cell multiomics: a new frontier in drug research and development
Jian Ma, Chao Dong, Aibin He, et al.
Frontiers in Drug Discovery (2024) Vol. 4
Open Access
Page 1

Scroll to top